PCI can be considered for noninfarct artery in STEMI

October 22, 2015

PCI can be considered for noninfarct artery in STEMI
(HealthDay)—For select patients with ST-segment elevation myocardial infarction (STEMI) with multivessel disease undergoing percutaneous coronary intervention (PCI), PCI in the noninfarct artery should be considered, according to new guidelines published online Oct. 21 in the Journal of the American College of Cardiology.

Glenn N. Levine, M.D., from the Baylor College of Medicine in Houston, and colleagues updated existing clinical practice guideline recommendations and added new recommendations on PCI for patients with STEMI.

Noting that about 50 percent of patients with STEMI have multivessel disease, the authors modified and upgraded the 2013 class III recommendation against PCI in a noninfarct artery at the time of primary PCI to a class IIB recommendation, in support of considering PCI in a noninfarct artery in select patients who are hemodynamically stable. Multivessel PCI should not be accepted as routine practice in with STEMI and multivessel disease; rather, physicians should integrate clinical data, lesion severity/complexity, and risk of contrast nephropathy to determine the optimal strategy when considering multivessel PCI. In addition, the authors modified the recommendation from IIa to IIb for selective and bailout aspiration thrombectomy before PCI, as the usefulness is not well established. The new recommendation established that there was no benefit for routine aspiration thrombectomy before primary PCI.

"This document is intended to provide a timely update based on new evidence to assist clinical decision making," Levine said in a statement.

Several members of the writing committees and reviewers disclosed financial ties to the pharmaceutical and medical device industries.

Explore further: Cardiac prognosis bright for STEMI survivors post-PCI

More information: Full Text (subscription or payment may be required)

Related Stories

Cardiac prognosis bright for STEMI survivors post-PCI

November 11, 2014
(HealthDay)—Patients who survive the first month after an ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) have

Preventive PCI results in better outcomes than culprit artery PCI alone in ST elevation MI

September 1, 2013
Heart attack patients with ST elevation who undergo a preventive procedure to unblock additional coronary arteries have significantly better outcomes than those whose treatment is confined to the culprit blockage only, according ...

Risk of adverse outcomes up with PCI in adults with diabetes

November 20, 2014
(HealthDay)—For adults with diabetes and multivessel or left main coronary artery disease, percutaneous coronary intervention (PCI) is associated with increased likelihood of a composite outcome compared with coronary artery ...

Cyclosporine does not improve outcomes after PCI

August 30, 2015
The immunosuppressant drug cyclosporine did not improve clinical outcomes compared to placebo in patients receiving percutaneous coronary intervention (PCI) for the more severe form of heart attack known as ST-segment elevation ...

Rate of PCI for coronary artery disease drops in the US

November 3, 2014
(HealthDay)—In the past several years, the rate of percutaneous coronary intervention (PCI) for coronary artery disease (CAD) has decreased in the United States, according to research published in the Oct. 1 issue of The ...

Heart attack patients taken to PCI hospitals first treated faster

May 10, 2012
Heart attack patients in North Carolina who were rushed directly to hospitals equipped to do percutaneous coronary intervention (PCI) received treatment significantly faster than patients first taken to hospitals unequipped ...

Recommended for you

Heart failure patients shouldn't stop meds even if condition improves: study

November 13, 2018
(HealthDay)—There's bad news for heart failure patients with dilated cardiomyopathy who'd like to stop taking their meds.

Bypass beats stents for diabetics with heart trouble: study

November 13, 2018
(HealthDay)—People with both diabetes and multiple clogged heart arteries live longer if they undergo bypass surgery rather than have their blood vessels reopened with stents, according to follow-up results from a landmark ...

Kawasaki disease: One disease, multiple triggers

November 12, 2018
Researchers at University of California San Diego School of Medicine, Scripps Institution of Oceanography, and international collaborators have evidence that Kawasaki Disease (KD) does not have a single cause. By studying ...

New treatment significantly reduces cardiovascular events when combined with statins

November 12, 2018
Statins are the most commonly used treatment for cardiovascular disease. Despite reducing certain risk factors, if triglyceride levels remain high with use of statins, there is still a significant risk for heart attack, stroke ...

Study: How vitamin D and fish oil affect risk of heart attack, stroke and cancer

November 12, 2018
For years, it's remained an open question: What effects do dietary supplements such as high doses of vitamin D or omega-3 fatty acids derived from fish oil have on the risk of diseases such as heart attack, stroke and cancer? ...

Diabetes drug might also ease heart failure risks

November 12, 2018
(HealthDay)—The diabetes drug Farxiga might do double-duty for patients, helping to ward off another killer, heart failure, new research shows.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.